tiprankstipranks
DigiPath Inc (DIGP)
OTHER OTC:DIGP
US Market

DigiPath (DIGP) Stock Price & Analysis

9 Followers

DIGP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.07
Previous Close$0.03
Volume50.70K
Average Volume (3M)73.09K
Market Cap
$2.74M
Enterprise Value$3.08M
Total Cash (Recent Filing)$325.59K
Total Debt (Recent Filing)$665.00K
Price to Earnings (P/E)4.2
Beta-0.20
Feb 18, 2025
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding87,096,820
10 Day Avg. Volume121,137
30 Day Avg. Volume73,090
Standard Deviation0.30
R-Squared0.02
Alpha-0.00948
Financial Highlights & Ratios
Price to Book (P/B)-1.33
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)10.60
P/FCF Ratio4.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.14
Enterprise Value/Gross Profit2.89
Enterprise Value/Ebitda-4.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

15.47%0.00%0.00%84.53%
15.47%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
84.53% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

DIGP FAQ

What was DigiPath Inc’s price range in the past 12 months?
DigiPath Inc lowest stock price was <$0.01 and its highest was $0.07 in the past 12 months.
    What is DigiPath Inc’s market cap?
    Currently, no data Available
    When is DigiPath Inc’s upcoming earnings report date?
    DigiPath Inc’s upcoming earnings report date is Feb 18, 2025 which is in 292 days.
      How were DigiPath Inc’s earnings last quarter?
      DigiPath Inc released its earnings results on Feb 13, 2024. The company reported $0.002 earnings per share for the quarter, beating the consensus estimate of N/A by $0.002.
        Is DigiPath Inc overvalued?
        According to Wall Street analysts DigiPath Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does DigiPath Inc pay dividends?
          DigiPath Inc does not currently pay dividends.
          What is DigiPath Inc’s EPS estimate?
          DigiPath Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does DigiPath Inc have?
          DigiPath Inc has 87,096,820 shares outstanding.
            What happened to DigiPath Inc’s price movement after its last earnings report?
            DigiPath Inc reported an EPS of $0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of DigiPath Inc?
              Currently, no hedge funds are holding shares in DIGP
              ---

              DigiPath Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              29.00%
              Trailing 12-Months

              Company Description

              DigiPath Inc

              DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. It operates through the Digipath Labs and GroSciences business units. The Digipath Labs business unit focuses on testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures. The GroSciences business unit plans to develop and license specific formulations to other producers and product makers in the industry. The company was founded by Todd Denkin on October 5, 2010 and is headquartered in Las Vegas, NV.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Soligenix
              Lexicon Pharmaceuticals
              Canopy Growth
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis